IRIDEX (IRIX)
(Delayed Data from NSDQ)
$1.89 USD
-0.08 (-4.06%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $1.88 -0.01 (-0.53%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth C Momentum B VGM
Income Statements
Fiscal Year end for IRIDEX Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 52 | 57 | 54 | 36 | 43 |
Cost Of Goods | 30 | 32 | 31 | 21 | 26 |
Gross Profit | 22 | 25 | 23 | 16 | 18 |
Selling & Adminstrative & Depr. & Amort Expenses | 32 | 33 | 30 | 22 | 27 |
Income After Depreciation & Amortization | -10 | -8 | -8 | -7 | -9 |
Non-Operating Income | 1 | 0 | 2 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -9 | -7 | -5 | -6 | -9 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -10 | -8 | -5 | -6 | -9 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -10 | -8 | -5 | -6 | -9 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -9 | -7 | -7 | -6 | -8 |
Depreciation & Amortization (Cash Flow) | 1 | 0 | 1 | 1 | 1 |
Income After Depreciation & Amortization | -10 | -8 | -8 | -7 | -9 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 16.13 | 15.94 | 15.42 | 13.84 | 13.71 |
Diluted EPS Before Non-Recurring Items | -0.59 | -0.47 | -0.34 | -0.46 | -0.64 |
Diluted Net EPS (GAAP) | -0.59 | -0.47 | -0.34 | -0.46 | -0.64 |
Fiscal Year end for IRIDEX Corporation falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 12.63 | 11.76 | 12.46 | 12.85 | 12.86 |
Cost Of Goods | 7.50 | 7.30 | 7.57 | 7.23 | 7.49 |
Gross Profit | 5.14 | 4.46 | 4.88 | 5.62 | 5.36 |
SG&A, R&D, and Dept/Amort Expenses | 7.77 | 7.76 | 7.96 | 7.31 | 8.26 |
Income After SG&A, R&D, and Dept/Amort Expenses | -2.63 | -3.30 | -3.08 | -1.69 | -2.90 |
Non-Operating Income | -0.02 | -0.13 | 0.18 | -0.06 | 0.14 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -2.66 | -3.43 | -2.90 | -1.75 | -2.76 |
Income Taxes | 0.02 | 0.04 | 0.06 | 0.01 | 0.01 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -2.68 | -3.46 | -2.96 | -1.75 | -2.77 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -2.68 | -3.46 | -2.96 | -1.75 | -2.77 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 16.29 | 16.25 | 16.25 | 16.23 | 16.04 |
Diluted EPS Before Non-Recurring Items | -0.16 | -0.21 | -0.18 | -0.11 | -0.17 |
Diluted Net EPS (GAAP) | -0.16 | -0.21 | -0.18 | -0.11 | -0.17 |